We are live on
!
Find out more
TCM
Towercrest Capital Management Portfolio holdings
AUM
$642M
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter
Est. Return
-12.63%
1 Year Est. Return
+11.71%
3 Year Est. Return
+31.42%
5 Year Est. Return
+23.73%
10 Year Est. Return
+78.8%
AUM
$333M
AUM Growth
-$58.3M
(-15%)
Cap. Flow
-$2.89M
Cap. Flow
% of AUM
-0.87%
Top 10 Holdings %
Top 10 Hldgs %
49.9%
Holding
87
New
8
Increased
31
Reduced
31
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$3.47M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$3.06M |
| 3 |
State Street SPDR Portfolio Emerging Markets ETF
SPEM
|
+$2.38M |
| 4 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$2.13M |
| 5 |
iShares Core Dividend Growth ETF
DGRO
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Floating Rate Bond ETF
FLOT
|
+$5.35M |
| 2 |
American International
AIG
|
+$4.91M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.33M |
| 4 |
Schwab US Large- Cap ETF
SCHX
|
+$2.23M |
| 5 |
Schwab US Broad Market ETF
SCHB
|
+$2.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.77% |
| 2 | Financials | 1.08% |
| 3 | Healthcare | 1% |
| 4 | Communication Services | 0.79% |
| 5 | Consumer Staples | 0.22% |
Similar funds
APC
RR
GECH
WHGAM
OP
PCM
CRCM
SFG
Towercrest Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Towercrest Capital Management held 87 positions worth $333M, down 15% from $391M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Towercrest Capital Management's Q1 2020 filing shows 8 new, 31 increased, 31 reduced and 9 closed positions. Its largest new stake was Iovance Biotherapeutics: 25,000 shares worth $748K. The largest sale was iShares Floating Rate Bond ETF, an estimated $5.35M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.5% a quarter earlier, followed by Financials and Healthcare.
- Towercrest Capital Management's largest Q1 2020 buy was Iovance Biotherapeutics: 25,000 shares worth $748K.
- Towercrest Capital Management added most to State Street SPDR Portfolio Developed World ex-US ETF in Q1 2020, an estimated $3.47M increase.
- Towercrest Capital Management's biggest Q1 2020 reduction was iShares Floating Rate Bond ETF, cutting an estimated $5.35M.
- Towercrest Capital Management fully exited Vanguard Real Estate ETF in Q1 2020, selling an estimated $1.64M.
- Towercrest Capital Management's ten largest holdings make up 50% of its $333M portfolio in Q1 2020.
- Towercrest Capital Management opened 8 new positions and closed 9 in Q1 2020.
- Towercrest Capital Management's portfolio value fell 15% quarter-over-quarter to $333M.
Based on Towercrest Capital Management's 13F filing for Q1 2020, filed 14 May 2020.